Evaluating traditional Chinese medicine for treating pulmonary nodules
Respiratory Disease Cohort Studies of Chinese Medicine for Pulmonary Nodule （RESEARCH-PN）
This study is testing if traditional Chinese medicine can help people with pulmonary nodules found on chest scans by comparing their health over two years with those who don't receive the treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 5000 (estimated) |
| Sex | All |
| Sponsor | Third Affiliated Hospital of Henan University of Traditional Chinese Medicine Academic / other |
| Locations | 1 site (Zhengzhou, Henan) |
| Trial ID | NCT06673121 on ClinicalTrials.gov |
What this trial studies
This multicenter, prospective cohort study aims to assess the effects of traditional Chinese medicine on patients with pulmonary nodules identified through chest HRCT scans. A total of at least 2244 individuals will be recruited and divided into two groups: those receiving traditional Chinese medicine treatment and those who are not. Participants will be followed for a minimum of two years, with primary outcomes focusing on the growth or regression of pulmonary nodules. Secondary outcomes will include various health assessments related to the nodules and the patients' mental well-being.
Who should consider this trial
Good fit: Ideal candidates are patients with pulmonary nodules who have been recommended for follow-up by a multidisciplinary team.
Not a fit: Patients with metastatic pulmonary nodules or those with benign conditions that do not require treatment may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide insights into the effectiveness of traditional Chinese medicine in managing pulmonary nodules, potentially offering a new treatment option.
How similar studies have performed: While traditional Chinese medicine has been explored in various contexts, this specific approach to treating pulmonary nodules is relatively novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: ① Patients with pulmonary nodules and recommended for follow-up by MDT; ② Voluntarily sign the informed consent form. Exclusion Criteria: ①Patients with metastatic pulmonary nodules; ②Patients with benign diseases such as pulmonary lymph nodes, hamartomas, sclerosing alveolar cell tumors, or nodules with obvious benign features such as calcification; ③Patients withserious heart, lung, liver and kidney diseases.
Where this trial is running
Zhengzhou, Henan
- The Third Affiliated Hospital of Henan University of Traditional Chinese Medicine — Zhengzhou, Henan, China (Recruiting)
Study contacts
- Study coordinator: Miao zhou
- Email: k1956f31@163.com
- Phone: 13733829100
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.